Published in:
01-06-2017 | Hepatitis B (J Lim, Section Editor)
Management of Chronic Hepatitis B in Children
Authors:
Danielle Wendel, Karen F. Murray
Published in:
Current Hepatology Reports
|
Issue 2/2017
Login to get access
Abstract
Purpose of Review
Management of chronic hepatitis B infection poses significant challenges for pediatric providers. Determination of who and when to treat can be difficult as long-term complications such as cirrhosis or hepatocellular carcinoma should be prevented while minimizing the risk of antiviral resistance.
Recent Findings
Many pediatric patients with chronic HBV will achieve natural loss of the HBeAg. Current regimens may be helpful in the setting of active hepatitis with a goal of viral suppression. Even in the rare case of HBsAg loss, viral DNA remains within hepatocytes where it can reactivate. Future treatment regimens being investigated target multiple aspects of the HBV life cycle to improve treatment efficacy.
Summary
Current management strategies involve close monitoring of patients with selective treatment only, so as to limit resistant strains. Future treatments with a variety of therapeutic targets will likely improve and potentially provide a virological cure for chronic HBV infection.